Swiss Drug Giant Roche to Cut 1,000 US Jobs and Close NJ Plant

By Bizclik Editor

Pharmaceutical giant Roche has announced that it will be shutting down its massive research and development center in Nutley, New Jersey and cutting 1,000 jobs in the process.

Additionally, Jean-Jacques Garaud, head of Roche Pharma Research and Early Development, will leave the company at the end of this month to be replaced by Mike Burgess, head of cancer drugs.

Roche says that it wants to redistribute its research activities to facilities in Switzerland and Germany and better control its drug development costs in the face of increasing experimental drug research.

“The planned consolidation of our research and early development organization and the refocusing of research and development activities in Switzerland and Germany will free up resources that we can invest in these promising clinical programs while also increasing our overall efficiency,” said Roche CEO Severin Schwan in a statement. “In its 80-year-old history, our Nutley site has made significant contributions to Roche’s success. We will do everything we can to find socially responsible solutions for the employees affected by these changes.”

Closing the New Jersey plant will allow Roche to maintain its current drug development costs despite a rise in clinical research projects over the past 18 months. The company’s existing facilities in Basel and Schlieren in Switzerland and Penzberg, Germany will handle Roche’s dislocated oncology, virology, metabolism and neuroscience programs, with only 80 additional staffers.

Although the company is ceasing lab research on the East Coast, it says it does plan to open a new transitional research center with approximately 240 workers by January 2013.


Featured Articles

Microsoft, McDonald’s latest firms to run civil rights audit

Microsoft and McDonald’s join Amazon, Citi, JPMorgan and others in conducting civil rights audits, as investor pressure to achieve racial equity mounts

Deep dive: Investment in carbon capture rises as CO2 spikes

Investment in carbon removal solutions and startups is heating up as fast as the planet, with Temasek and CEMEX Ventures the latest VCs to launch funds

Dialight envisions a safe industrial world with LED lights

Reliance on inefficient lighting technologies are not only harmful to the environment, but also increase injury risk and cost

Top 10: Tech, cyber, 5G, cloud speakers at TECH LIVE LONDON

Technology & AI

Eight big announcements made at Davos 2022, from ESG to tech


Hear Vodafone Business cyber chief Kawalec at Cyber LIVE

Leadership & Strategy